Takeda Pharmaceuticals India Pvt Ltd. (Amalgamated) - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Takeda Pharma

M-Cap below 100cr DeciZen not available

Takeda Pharmaceuticals India Pvt Ltd. (Amalgamated) stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Takeda Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16TTM
ROCE % 9.2%0.1%0.1%10.1%17.2%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.9019.929.536.336
Sales YoY Gr.--100%NA48.2%23.1%-
Adj EPS 0.6-0.2-1.21.74.90
YoY Gr.--126.3%NANA183.3%-
BVPS (₹) 10.623.12222.827.10
Adj Net
Profit
0.3-0.1-0.60.92.50
Cash Flow from Ops. 0000.51.9-
Debt/CF from Ops. 00000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA23.1%
Adj EPS NANANA183.3%
BVPSNANA5.6%18.9%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'12Mar'13Mar'14Mar'15Mar'16TTM
Return on
Equity %
5.4-0.9-5.57.819.80
Op. Profit
Mgn %
16.903.58.99.9NAN
Net Profit
Mgn %
27.80-3.136.80
Debt to
Equity
00000-
Working Cap
Days
00110871040
Cash Conv.
Cycle
00-2-31-180

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Takeda Pharmaceuticals India Pvt Ltd. (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 36.3 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 9 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 44.7

Management X-Ray of Takeda Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Takeda Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16
Sales0.93019.9129.5036.32
Operating Expenses 0.778.8519.2227.5333.19
Manufacturing Costs00.010.120.130.11
Material Costs0000.461.52
Employee Cost 0.452.757.721015.79
Other Costs 0.336.0911.3716.9515.76
Operating Profit 0.16-8.850.701.973.13
Operating Profit Margin (%) 16.9%-3.5%6.7%8.6%
Other Income 0.288.990.360.320.31
Interest 00.010.010.040.05
Depreciation 00.131.051.161.29
Exceptional Items 00000
Profit Before Tax 0.44001.082.10
Tax 0.180.050.540.66-0.05
Profit After Tax 0.26-0.05-0.540.422.14
PAT Margin (%) 27.8%--2.7%1.4%5.9%
Adjusted EPS (₹)0.6-0.1-1.10.84.3
Dividend Payout Ratio (%)0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16

Equity and Liabilities

Shareholders Fund 4.7611.5010.9611.3813.52
Share Capital 4.504.994.994.994.99
Reserves 0.266.515.976.398.54
Minority Interest00000
Debt00000
Long Term Debt00000
Short Term Debt00000
Trade Payables000.632.022.23
Others Liabilities 0.263.033.654.996.66
Total Liabilities 5.0214.5315.2418.3922.42

Fixed Assets

Gross Block02.174.935.345.30
Accumulated Depreciation00.141.182.293.47
Net Fixed Assets02.033.753.051.83
CWIP 00000
Investments 00000
Inventories0000.362.24
Trade Receivables0.931.0400.070.30
Cash Equivalents 4.095.936.126.588.71
Others Assets05.535.378.329.34
Total Assets 5.0214.5315.2418.3922.42

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16
Cash Flow From Operating Activity 0.461.92
PBT 1.082.10
Adjustment 0.930.76
Changes in Working Capital -0.82-0.04
Tax Paid -0.73-0.90
Cash Flow From Investing Activity -0.46-0.12
Capex -0.46-0.12
Net Investments 00
Others 00
Cash Flow From Financing Activity 0.47-0.67
Net Proceeds from Shares 00
Net Proceeds from Borrowing 00
Interest Paid 0.470.33
Dividend Paid 00
Others 0-1
Net Cash Flow 0.471.13
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16
Ratios
ROE (%)5.43-0.61-4.823.7617.22
ROCE (%)9.180.060.0510.117.23
Asset Turnover Ratio0.1901.341.751.78
PAT to CFO Conversion(x)1.77N/AN/A00
Working Capital Days
Receivable Days3650012
Inventory Days000413
Payable Days0001,058509

Takeda Pharmaceuticals India Pvt Ltd. (Amalgamated) Stock News

Takeda Pharmaceuticals India Pvt Ltd. (Amalgamated) FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Takeda Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Takeda Pharma stood at ₹0.00.
The latest P/E ratio of Takeda Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Takeda Pharma as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Takeda Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Takeda Pharma is ₹36.32 ( Cr.) .

About Takeda Pharmaceuticals India Pvt Ltd. (Amalgamated)

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.